Name: 글로벌 시장 동향
SKU: CD1058
Availability: InStock

보고서 요약(국문)

보고서 개요
글로벌 체외 진단(IVD) 시장은 2023년 983억 달러 규모에 도달했으며, 2024년부터 2031년까지 연평균 5.3% 성장하여 2031년에는 1,457억 달러에 이를 것으로 예상됩니다.
체외 진단(IVD)은 인체 검체를 사용하여 질병, 질환 또는 감염을 진단하는 검사 분야입니다. 이러한 검사는 일반적으로 실험실 환경에서 첨단 장비와 시약을 사용하여 체외에서 수행됩니다. IVD는 질병 진단, 치료 결정 및 환자 건강 모니터링에 중요한 정보를 제공함으로써 현대 의학에서 매우 중요합니다. IVD 시장은 기술 발전, 세계 고령화, 만성 질환 및 맞춤형 의학 수요 증가로 인해 빠르게 성장하고 있습니다.
시장 동향: 동인 및 제약 요인
기술 발전의 증가
기술 발전의 증가는 예측 기간 동안 시장 성장에 기여할 것입니다. PCR 및 NGS를 포함한 분자 진단은 유전 질환의 조기 발견을 가능하게 하여 진단 정확도와 치료 결과를 향상시킵니다. 현장 진단 기기는 원격 환경에서 더 빠른 진단과 치료를 가능하게 합니다. 체외 진단 시스템의 자동화 및 디지털화는 효율성을 향상시키고, 인적 오류를 줄이며, 특히 원격 환경에서 더 정확한 결과를 제공합니다.
새롭고 정확도가 높은 임상 검사의 도입은 전 세계적으로 새로운 체외 진단 검사의 도입을 촉진하고 있습니다. 예를 들어, 2023년 6월, 도레이 공업(Toray Industries, Inc.)은 췌장암 진단에 사용되는 도레이 APOA2-iTQ에 대해 일본 후생노동성으로부터 시판 승인을 받았습니다.
또한, 2023년 3월, 애보트(Abbott)는 외상성 뇌손상(TBI) 혈액 검사에 대해 미국 식품의약국(FDA)의 승인을 받았습니다. 생명을 위협하는 질병에 대한 체외 진단 검사의 승인이 증가함에 따라 미개척 시장에서 새로운 기회가 창출될 것으로 예상됩니다.
숙련된 전문가 부족
전 세계 체외 진단 시장은 엄격한 규제 요건, 첨단 진단 기술의 높은 비용, 숙련된 전문가 부족 등 여러 가지 문제에 직면해 있습니다. 이러한 요인들은 새로운 진단 제품의 시장 진입을 지연시키고 의료 예산이 제한적인 개발도상국에서의 도입을 저해할 수 있습니다. 전반적으로 이러한 요인들은 체외 진단(IVD) 시장에서 사업을 운영하는 기업들에게 상당한 어려움을 야기합니다.
시장 세분화 분석
글로벌 체외 진단 시장은 제품 유형, 기술, 응용 분야, 최종 사용자 및 지역별로 세분화됩니다.
제품 유형 부문에서 시약은 체외 진단 시장 점유율의 약 41.3%를 차지했습니다.
시약은 환자 검체에서 생물학적 표지자를 검출하고 정량화하는 데 필수적인 체외 진단 구성 요소입니다. 시약은 표적 분석물질과 반응하도록 설계되어 질병, 질환 또는 감염을 식별하고 측정할 수 있게 합니다. 시약은 진단 검사의 정확성과 신뢰성에 매우 중요하며 결과의 민감도와 특이도에 직접적인 영향을 미칩니다. 시약은 면역 분석, 분자 진단, 임상 화학 및 혈액학을 포함한 다양한 진단 응용 분야에 사용됩니다. 맞춤형 의학의 성장과 신속 진단으로 인해 고품질 시약에 대한 수요가 증가하고 있습니다. 예를 들어, 2023년 10월 미국에 본사를 둔 화학 공급업체 알파 케미스트리(Alfa Chemistry)는 실험실용 체외 진단(IVD) 제품 3종을 출시하여 혈액이나 조직과 같은 샘플 검사를 통해 질병을 진단하는 연구를 지원하는 생물학적 시약 제품군을 강화했습니다.
시장 지역별 점유율
북미는 예측 기간 동안 전체 시장 점유율의 약 38.4%를 차지할 것으로 예상됩니다.
북미는 만성 질환 발생률 증가, 주요 업체들의 존재, 신규 진단 검사 출시 증가, 그리고 정부의 지원 자금 등으로 인해 예측 기간 동안 전체 시장 점유율의 약 38.4%를 차지할 것으로 예상됩니다.
예를 들어, 2023년 1월 BD와 CerTest Biotec은 미국 식품의약국(FDA)으로부터 천연두 바이러스(Mpox virus) 검출용 PCR 검사에 대한 긴급사용승인(EUA)을 받았습니다. 또한, 당뇨병 및 암과 같은 개인 맞춤형 건강 관리를 위한 유전자 검사에 대한 수요 증가가 북미 시장 성장을 견인할 것으로 예상됩니다.

시장 세분화
제품 유형별
기기
시약
소프트웨어 및 서비스
기술별
면역 분석법
현장 진단(POC)
분자 진단
혈액학
조직 진단
미생물학
자가 혈당 측정
기타
응용 분야별
감염성 질환
당뇨병
암/종양학
심장학
자가면역 질환
신장학
약물 검사
기타
최종 사용자별
진단 실험실
병원
학술 및 연구 기관
기타
지역별
북미
미국
캐나다
멕시코
유럽
독일
영국
프랑스
이탈리아
스페인
기타 유럽
남미
브라질
아르헨티나
기타 남미
아시아 태평양
중국
인도
일본
한국
기타 아시아 태평양
중동 및 아프리카
시장 경쟁 구도
주요 글로벌 시장 참여 기업으로는 BioMérieux, Danaher Corporation, Roche Diagnostics, Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Abbott Laboratories, Bayer AG, Arkray, Inc., Sysmex Corporation, Siemens AG 등이 있습니다.
주요 개발 사항
ELITech Group은 2024년 1월, 자사의 진단 포트폴리오에 새롭게 추가된 강력한 제품인 GI Bacterial PLUS ELITe MGB 키트를 출시한다고 발표했습니다. 위장관 세균 감염 진단에 특화된 이 체외 진단 키트는 Campylobacter spp.를 포함한 주요 병원성 세균만을 표적으로 합니다.

2023년 9월, 벵갈루루에 본사를 둔 스타트업 NeoDx Biotech Labs는 강직성 척추염 진단을 위한 실시간 PCR 기술 기반 체외 진단(IVD) 키트를 출시하여 의료 서비스 제공업체의 검사 역량 향상을 지원했습니다.
보고서 구매 이유:
제품 유형, 기술, 응용 분야, 최종 사용자 및 지역별 글로벌 체외 진단 시장 세분화를 시각화하고 주요 상업 자산 및 기업을 파악하기 위함입니다.
트렌드 분석 및 공동 개발을 통해 사업 기회를 발굴할 수 있습니다.
모든 세그먼트를 포함한 체외 진단 시장 수준의 다양한 데이터 포인트가 담긴 Excel 데이터 시트를 제공합니다.
PDF 보고서는 심층적인 질적 인터뷰와 연구를 바탕으로 한 종합적인 분석 결과를 담고 있습니다.
주요 기업의 핵심 제품을 모두 포함하는 제품 맵핑 Excel 파일을 제공합니다.
글로벌 체외 진단 시장 보고서는 약 64개의 표, 61개의 그림, 그리고 186페이지 분량으로 구성됩니다.

2024년 목표 고객층
제조업체/구매자
산업 투자자/투자은행가
연구 전문가
신흥 기업

보고서 요약(영어 원문)

Report Overview
Global In Vitro Diagnostics Market reached US$ 98.3 billion in 2023 and is expected to reach US$ 145.7 billion by 2031, growing at a CAGR of 5.3% during the forecast period 2024-2031
In Vitro Diagnostics (IVD) is a field of tests used to detect diseases, conditions, or infections using human samples. These tests are conducted outside the body, typically in laboratory settings, using advanced instruments and reagents. IVD is crucial in modern medicine, providing critical information for disease diagnosis, treatment decisions, and monitoring patient health. The market for IVD is rapidly growing due to technological advancements, an aging global population, chronic diseases, and personalized medicine demand.
Market Dynamics: Drivers & Restraints
Rise in technological advancements
The rise in technological advancements help the market to grow during the forecast period. Molecular diagnostics, including PCR and NGS, enable early genetic disease detection, improving diagnosis accuracy and treatment outcomes. Point-of-care testing devices enable faster diagnosis and treatment in remote settings. Automation and digitalization in IVD systems improve efficiency, reduce human error, and provide more accurate results, especially in remote settings.
The introduction of novel and highly accurate clinical laboratory tests is boosting the adoption of novel IVD tests worldwide. For instance, in June 2023, Toray Industries, Inc. received marketing approval from Japan’s Ministry of Health, Labour and Welfare for its Toray APOA2-iTQ used to diagnose pancreatic cancer.
Moreover, in March 2023, Abbott received U.S. FDA clearance for its novel laboratory Traumatic Brain Injury (TBI) blood test in the U.S. Increasing approvals of IVD tests for life-threatening diseases are expected to create new opportunities in the untapped market.
Lack of skilled professionals
The global in vitro diagnostics market faces several challenges, including stringent regulatory requirements, high costs of advanced diagnostic technologies, and a lack of skilled professionals. These factors can delay the entry of new diagnostic products and limit their adoption in developing countries with limited healthcare budgets. Overall, these factors pose significant challenges for companies operating in the IVD market.
Market Segment Analysis
The global in vitro diagnostics market is segmented based on product type, technique, application, end-user, and region.
The reagents from the product type segment accounted for approximately 41.3% of the in vitro diagnostics market share
The reagents from the product type segment accounted for approximately 41.3%. Reagents are essential components in in vitro diagnostics for detecting and quantifying biological markers in patient samples. They are designed to react with target analytes, enabling the identification and measurement of diseases, conditions, or infections. Reagents are crucial for the accuracy and reliability of diagnostic tests, directly affecting the sensitivity and specificity of results. They are used in various diagnostic applications, including immunoassays, molecular diagnostics, clinical chemistry, and hematology. The demand for high-quality reagents has increased due to personalized medicine growth and rapid diagnostics.
For instance, in October 2023, US-based chemical supplier Alfa Chemistry introduced three IVD products for laboratory use, enhancing its range of biological reagents, to aid in research on diseases detected through tests on samples like blood or tissue.
Market Geographical Share
North America is estimated to hold about 38.4% of the total market share throughout the forecast period
North America is estimated to hold about 38.4% of the total market share throughout the forecast period due rising incidence of chronic diseases, the presence of strong players, the increasing number of novel test launches, and supportive government funding.
For instance, in January 2023, BD and CerTest Biotec received EUA from the U.S. FDA for a PCR test for Mpox virus detection in the U.S. Moreover, the increasing requirement for genetic testing for personalized health care, such as that for diabetes and cancer, is expected to drive market growth in North America.
Market Segmentation
By-Product Type
Instruments
Reagents
Software and Services
By Technique
Immunoassays
POC diagnostics
Molecular diagnostics
Hematology
Tissue diagnostics
Microbiology
Self-Blood-Glucose Monitoring
Others
By Application
Infectious Diseases
Diabetes
Cancer/Oncology
Cardiology
Autoimmune Diseases
Nephrology
Drug Testing
Others
By End User
Diagnostic Laboratories
Hospitals
Academics and Research Institutes
Others
By Region
North America
The U.S.
Canada
Mexico
Europe
Germany
UK
France
Italy
Spain
Rest of Europe
South America
Brazil
Argentina
Rest of South America
Asia-Pacific
China
India
Japan
South Korea
Rest of Asia-Pacific
Middle East and Africa
Market Competitive Landscape
The major global players in the market include BioMérieux, Danaher Corporation, Roche Diagnostics, Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Abbott Laboratories, Bayer AG, Arkray, Inc., Sysmex Corporation, Siemens AG among others.
Key Developments
In January 2024, ELITech Group proudly announces the introduction of the GI Bacterial PLUS ELITe MGB Kit, a robust addition to its diagnostic portfolio. Tailored specifically for diagnosing gastrointestinal bacterial infections, the in vitro assay exclusively targets major bacterial pathogens including Campylobacter spp.
In September 2023, NeoDx Biotech Labs, a Bengaluru-based startup launched a Real-time PCR-Technology-based in vitro diagnostic (IVD) kit for Ankylosing Spondylitis & empowered healthcare services to improve their testing capabilities.
Why Purchase the Report?
To visualize the global in vitro diagnostics market segmentation based on product type, technique, application, end-user, and region as well as understand key commercial assets and players.
Identify commercial opportunities by analyzing trends and co-development.
Excel data sheet with numerous data points of the in vitro diagnostics market level with all segments.
PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
Product mapping available as excel consisting of key products of all the major players.
The global in vitro diagnostics market report would provide approximately 64 tables, 61 figures, and 186 pages.
Target Audience 2024
Manufacturers/ Buyers
Industry Investors/Investment Bankers
Research Professionals
Emerging Companies

상세 목차

1. Methodology and Scope
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. Definition and Overview
3. Executive Summary
3.1. Snippet by Product Type
3.2. Snippet by Technique
3.3. Snippet by Application
3.4. Snippet by End User
3.5. Snippet by Region
4. Dynamics
4.1. Impacting Factors
4.1.1. Drivers
4.1.1.1. Rise in technological advancements
4.1.1.2. Rise in the prevalence of chronic diseases
4.1.2. Restraints
4.1.2.1. Lack of skilled professionals
4.1.2.2. XX
4.1.3. Opportunity
4.1.4. Impact Analysis
5. Industry Analysis
5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
5.5. Patent Analysis
5.6. PESTLE Analysis
5.7. SWOT Analysis
5.8. DMI Opinion
6. By Product Type
6.1. Introduction
6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
6.1.2. Market Attractiveness Index, By Product Type
6.2. Instruments*
6.2.1. Introduction
6.3. Reagents
6.4. Software and Services
7. By Technique
7.1. Introduction
7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technique
7.2. Market Attractiveness Index, By Technique
7.3. Immunoassays*
7.3.1. Introduction
7.3.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.4. POC diagnostics
7.5. Molecular diagnostics
7.6. Hematology
7.7. Tissue diagnostics
7.8. Microbiology
7.9. Self-Blood-Glucose Monitoring
7.10. Others
8. By Application
8.1. Introduction
8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
8.1.2. Market Attractiveness Index, By Application
8.2. Infectious Diseases*
8.2.1. Introduction
8.3. Diabetes
8.4. Cancer/Oncology
8.5. Cardiology
8.6. Autoimmune Diseases
8.7. Nephrology
8.8. Drug Testing
8.9. Others
9. By End User
9.1. Introduction
9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
9.1.2. Market Attractiveness Index, By End User
9.2. Diagnostic Laboratories*
9.2.1. Introduction
9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Hospitals
9.4. Academics and Research Institutes
9.5. Others
10. By Region
10.1. Introduction
10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
10.1.2. Market Attractiveness Index, By Region
10.2. North America
10.2.1. Introduction
10.2.2. Key Region-Specific Dynamics
10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technique
10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
10.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.2.7.1. The U.S.
10.2.7.2. Canada
10.2.7.3. Mexico
10.3. Europe
10.3.1. Introduction
10.3.2. Key Region-Specific Dynamics
10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technique
10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
10.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.3.7.1. Germany
10.3.7.2. UK
10.3.7.3. France
10.3.7.4. Italy
10.3.7.5. Spain
10.3.7.6. Rest of Europe
10.4. South America
10.4.1. Introduction
10.4.2. Key Region-Specific Dynamics
10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technique
10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
10.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.4.7.1. Brazil
10.4.7.2. Argentina
10.4.7.3. Rest of South America
10.5. Asia-Pacific
10.5.1. Introduction
10.5.2. Key Region-Specific Dynamics
10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technique
10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
10.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.5.7.1. China
10.5.7.2. India
10.5.7.3. Japan
10.5.7.4. South Korea
10.5.7.5. Rest of Asia-Pacific
10.6. Middle East and Africa
10.6.1. Introduction
10.6.2. Key Region-Specific Dynamics
10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technique
10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
11. Competitive Landscape
11.1. Competitive Scenario
11.2. Market Positioning/Share Analysis
11.3. Mergers and Acquisitions Analysis
12. Company Profiles
12.1. BioMérieux*
12.1.1. Company Overview
12.1.2. Product Portfolio and Description
12.1.3. Financial Overview
12.1.4. Key Developments
12.2. Danaher Corporation
12.3. Roche Diagnostics
12.4. Becton, Dickinson and Company
12.5. Bio-Rad Laboratories, Inc.
12.6. Abbott Laboratories
12.7. Bayer AG
12.8. Arkray, Inc
12.9. Sysmex Corporation
12.10. Siemens AG (*LIST NOT EXHAUSTIVE)
13. Appendix
13.1. About Us and Services
13.2. Contact Us

언급된 주요 기업들

BioMérieux, 4.	Key Developments, Danaher Corporation, Roche Diagnostics, Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Abbott Laboratories, Bayer AG, Arkray, Inc, Sysmex Corporation

표 목록 (Tables)

List of Tables

Table 1 Global In-Vitro Diagnostics Market Value, By Product Type, 2024, 2028 & 2032 (US$ Million)

Table 2 Global In-Vitro Diagnostics Market Value, By Technique Type, 2024, 2028 & 2032 (US$ Million)

Table 3 Global In-Vitro Diagnostics Market Value, By Application, 2024, 2028 & 2032 (US$ Million)

Table 4 Global In-Vitro Diagnostics Market Value, By End-User, 2024, 2028 & 2032 (US$ Million)

Table 5 Global In-Vitro Diagnostics Market Value, By Region, 2024, 2028 & 2032 (US$ Million)

Table 6 Global In-Vitro Diagnostics Market Value, By Product Type, 2024, 2028 & 2032 (US$ Million)

Table 7 Global In-Vitro Diagnostics Market Value, By Product Type, 2023-2032 (US$ Million)

Table 8 Global In-Vitro Diagnostics Market Value, By Technique Type, 2024, 2028 & 2032 (US$ Million)

Table 9 Global In-Vitro Diagnostics Market Value, By Technique Type, 2023-2032 (US$ Million)

Table 10 Global In-Vitro Diagnostics Market Value, By Application, 2024, 2028 & 2032 (US$ Million)

Table 11 Global In-Vitro Diagnostics Market Value, By Application, 2023-2032 (US$ Million)

Table 12 Global In-Vitro Diagnostics Market Value, By End-User, 2024, 2028 & 2032 (US$ Million)

Table 13 Global In-Vitro Diagnostics Market Value, By End-User, 2023-2032 (US$ Million)

Table 14 Global In-Vitro Diagnostics Market Value, By Region, 2024, 2028 & 2032 (US$ Million)

Table 15 Global In-Vitro Diagnostics Market Value, By Region, 2023-2032 (US$ Million)

Table 16 North America In-Vitro Diagnostics Market Value, By Product Type, 2023-2032 (US$ Million)

Table 17 North America In-Vitro Diagnostics Market Value, By Technique Type, 2023-2032 (US$ Million)

Table 18 North America In-Vitro Diagnostics Market Value, By Application, 2023-2032 (US$ Million)

Table 19 North America In-Vitro Diagnostics Market Value, By End-User, 2023-2032 (US$ Million)

Table 20 North America In-Vitro Diagnostics Market Value, By Country, 2023-2032 (US$ Million)

Table 21 South America In-Vitro Diagnostics Market Value, By Product Type, 2023-2032 (US$ Million)

Table 22 South America In-Vitro Diagnostics Market Value, By Technique Type, 2023-2032 (US$ Million)

Table 23 South America In-Vitro Diagnostics Market Value, By Application, 2023-2032 (US$ Million)

Table 24 South America In-Vitro Diagnostics Market Value, By End-User, 2023-2032 (US$ Million)

Table 25 South America In-Vitro Diagnostics Market Value, By Country, 2023-2032 (US$ Million)

Table 26 Europe In-Vitro Diagnostics Market Value, By Product Type, 2023-2032 (US$ Million)

Table 27 Europe In-Vitro Diagnostics Market Value, By Technique Type, 2023-2032 (US$ Million)

Table 28 Europe In-Vitro Diagnostics Market Value, By Application, 2023-2032 (US$ Million)

Table 29 Europe In-Vitro Diagnostics Market Value, By End-User, 2023-2032 (US$ Million)

Table 30 Europe In-Vitro Diagnostics Market Value, By Country, 2023-2032 (US$ Million)

Table 31 Asia-Pacific In-Vitro Diagnostics Market Value, By Product Type, 2023-2032 (US$ Million)

Table 32 Asia-Pacific In-Vitro Diagnostics Market Value, By Technique Type, 2023-2032 (US$ Million)

Table 33 Asia-Pacific In-Vitro Diagnostics Market Value, By Application, 2023-2032 (US$ Million)

Table 34 Asia-Pacific In-Vitro Diagnostics Market Value, By End-User, 2023-2032 (US$ Million)

Table 35 Asia-Pacific In-Vitro Diagnostics Market Value, By Country, 2023-2032 (US$ Million)

Table 36 Middle East and Africa In-Vitro Diagnostics Market Value, By Product Type, 2023-2032 (US$ Million)

Table 37 Middle East and Africa In-Vitro Diagnostics Market Value, By Technique Type, 2023-2032 (US$ Million)

Table 38 Middle East and Africa In-Vitro Diagnostics Market Value, By Application, 2023-2032 (US$ Million)

Table 39 Middle East and Africa In-Vitro Diagnostics Market Value, By End-User, 2023-2032 (US$ Million)

Table 40 Middle East and Africa In-Vitro Diagnostics Market Value, By Country, 2023-2032 (US$ Million)

Table 41 bioMerieux: Overview

Table 42 bioMerieux: Product Portfolio

Table 43 bioMerieux: Key Developments

Table 44 Becton, Dickinson and Company: Overview

Table 45 Becton, Dickinson and Company: Product Portfolio

Table 46 Becton, Dickinson and Company: Key Developments

Table 47 Beckman Coulter, Inc: Overview

Table 48 Beckman Coulter, Inc: Product Portfolio

Table 49 Beckman Coulter, Inc: Key Developments

Table 50 F. Hoffmann-La Roche Ltd.: Overview

Table 51 F. Hoffmann-La Roche Ltd.: Product Portfolio

Table 52 F. Hoffmann-La Roche Ltd.: Key Developments

Table 53 Bio-Rad Laboratories, Inc: Overview

Table 54 Bio-Rad Laboratories, Inc: Product Portfolio

Table 55 Bio-Rad Laboratories, Inc: Key Developments

Table 56 Abbott Laboratories: Overview

Table 57 Abbott Laboratories: Product Portfolio

Table 58 Abbott Laboratories: Key Developments

Table 59 Qiagen NV: Overview

Table 60 Qiagen NV: Product Portfolio

Table 61 Qiagen NV: Key Developments

Table 62 FUJIFILM Holdings Corporation: Overview

Table 63 FUJIFILM Holdings Corporation: Product Portfolio

Table 64 FUJIFILM Holdings Corporation: Key Developments

Table 65 Sysmex Corporation: Overview

Table 66 Sysmex Corporation: Product Portfolio

Table 67 Sysmex Corporation: Key Developments

Table 68 Siemens Healthineers AG: Overview

Table 69 Siemens Healthineers AG: Product Portfolio

Table 70 Siemens Healthineers AG: Key Developments

그림 목록 (Figures)

List of Figures

Figure 1 Global In-Vitro Diagnostics Market Value, 2023-2032 (US$ Million)

Figure 2 Global In-Vitro Diagnostics Market Share, By Product Type, 2024 & 2032 (%)

Figure 3 Global In-Vitro Diagnostics Market Share, By Technique Type, 2024 & 2032 (%)

Figure 4 Global In-Vitro Diagnostics Market Share, By Application, 2024 & 2032 (%)

Figure 5 Global In-Vitro Diagnostics Market Share, By End-User, 2024 & 2032 (%)

Figure 6 Global In-Vitro Diagnostics Market Share, By Region, 2024 & 2032 (%)

Figure 7 Global In-Vitro Diagnostics Market Y-o-Y Growth, By Product Type, 2024-2032 (%)

Figure 8 Instruments In-Vitro Diagnostics Market Value, 2023-2032 (US$ Million)

Figure 9 Reagents In-Vitro Diagnostics Market Value, 2023-2032 (US$ Million)

Figure 10 Software and Services In-Vitro Diagnostics Market Value, 2023-2032 (US$ Million)

Figure 11 Others In-Vitro Diagnostics Market Value, 2023-2032 (US$ Million)

Figure 12 Global In-Vitro Diagnostics Market Y-o-Y Growth, By Technique Type, 2024-2032 (%)

Figure 13 Immunoassays Technique Type in Global In-Vitro Diagnostics Market Value, 2023-2032 (US$ Million)

Figure 14 POC Diagnostics Technique Type in Global In-Vitro Diagnostics Market Value, 2023-2032 (US$ Million)

Figure 15 Molecular Diagnostics Technique Type in Global In-Vitro Diagnostics Market Value, 2023-2032 (US$ Million)

Figure 16 Hematology Technique Type in Global In-Vitro Diagnostics Market Value, 2023-2032 (US$ Million)

Figure 17 Tissue Diagnostics Technique Type in Global In-Vitro Diagnostics Market Value, 2023-2032 (US$ Million)

Figure 18 Microbiology Technique Type in Global In-Vitro Diagnostics Market Value, 2023-2032 (US$ Million)

Figure 19 Self-Blood-Glucose Monitoring Technique Type in Global In-Vitro Diagnostics Market Value, 2023-2032 (US$ Million)

Figure 20 Others Technique Type in Global In-Vitro Diagnostics Market Value, 2023-2032 (US$ Million)

Figure 21 Global In-Vitro Diagnostics Market Y-o-Y Growth, By Application, 2024-2032 (%)

Figure 22 Infectious Diseases Application in Global In-Vitro Diagnostics Market Value, 2023-2032 (US$ Million)

Figure 23 Diabetes Application in Global In-Vitro Diagnostics Market Value, 2023-2032 (US$ Million)

Figure 24 Oncology Application in Global In-Vitro Diagnostics Market Value, 2023-2032 (US$ Million)

Figure 25 Cardiology Application in Global In-Vitro Diagnostics Market Value, 2023-2032 (US$ Million)

Figure 26 Autoimmune Diseases Application in Global In-Vitro Diagnostics Market Value, 2023-2032 (US$ Million)

Figure 27 Nephrology Application in Global In-Vitro Diagnostics Market Value, 2023-2032 (US$ Million)

Figure 28 Drug Testing Application in Global In-Vitro Diagnostics Market Value, 2023-2032 (US$ Million)

Figure 29 Others Application in Global In-Vitro Diagnostics Market Value, 2023-2032 (US$ Million)

Figure 30 Global In-Vitro Diagnostics Market Y-o-Y Growth, By End-User, 2024-2032 (%)

Figure 31 Diagnostic Laboratories End-User in Global In-Vitro Diagnostics Market Value, 2023-2032 (US$ Million)

Figure 32 Hospitals End-User in Global In-Vitro Diagnostics Market Value, 2023-2032 (US$ Million)

Figure 33 Academics and Research Institutes End-User in Global In-Vitro Diagnostics Market Value, 2023-2032 (US$ Million)

Figure 34 Others End-User in Global In-Vitro Diagnostics Market Value, 2023-2032 (US$ Million)

Figure 35 Global In-Vitro Diagnostics Market Y-o-Y Growth, By Region, 2024-2032 (%)

Figure 36 North America In-Vitro Diagnostics Market Value, 2023-2032 (US$ Million)

Figure 37 North America In-Vitro Diagnostics Market Share, By Product Type, 2024 & 2032 (%)

Figure 38 North America In-Vitro Diagnostics Market Share, By Technique Type, 2024 & 2032 (%)

Figure 39 North America In-Vitro Diagnostics Market Share, By Application, 2024 & 2032 (%)

Figure 40 North America In-Vitro Diagnostics Market Share, By End-User, 2024 & 2032 (%)

Figure 41 North America In-Vitro Diagnostics Market Share, By Country, 2024 & 2032 (%)

Figure 42 South America In-Vitro Diagnostics Market Value, 2023-2032 (US$ Million)

Figure 43 South America In-Vitro Diagnostics Market Share, By Product Type, 2024 & 2032 (%)

Figure 44 South America In-Vitro Diagnostics Market Share, By Technique Type, 2024 & 2032 (%)

Figure 45 South America In-Vitro Diagnostics Market Share, By Application, 2024 & 2032 (%)

Figure 46 South America In-Vitro Diagnostics Market Share, By End-User, 2024 & 2032 (%)

Figure 47 South America In-Vitro Diagnostics Market Share, By Country, 2024 & 2032 (%)

Figure 48 Europe In-Vitro Diagnostics Market Value, 2023-2032 (US$ Million)

Figure 49 Europe In-Vitro Diagnostics Market Share, By Product Type, 2024 & 2032 (%)

Figure 50 Europe In-Vitro Diagnostics Market Share, By Technique Type, 2024 & 2032 (%)

Figure 51 Europe In-Vitro Diagnostics Market Share, By Application, 2024 & 2032 (%)

Figure 52 Europe In-Vitro Diagnostics Market Share, By End-User, 2024 & 2032 (%)

Figure 53 Europe In-Vitro Diagnostics Market Share, By Country, 2024 & 2032 (%)

Figure 54 Asia-Pacific In-Vitro Diagnostics Market Value, 2023-2032 (US$ Million)

Figure 55 Asia-Pacific In-Vitro Diagnostics Market Share, By Product Type, 2024 & 2032 (%)

Figure 56 Asia-Pacific In-Vitro Diagnostics Market Share, By Technique Type, 2024 & 2032 (%)

Figure 57 Asia-Pacific In-Vitro Diagnostics Market Share, By Application, 2024 & 2032 (%)

Figure 58 Asia-Pacific In-Vitro Diagnostics Market Share, By End-User, 2024 & 2032 (%)

Figure 59 Asia-Pacific In-Vitro Diagnostics Market Share, By Country, 2024 & 2032 (%)

Figure 60 Middle East and Africa In-Vitro Diagnostics Market Value, 2023-2032 (US$ Million)

Figure 61 Middle East and Africa In-Vitro Diagnostics Market Share, By Product Type, 2024 & 2032 (%)

Figure 62 Middle East and Africa In-Vitro Diagnostics Market Share, By Technique Type, 2024 & 2032 (%)

Figure 63 Middle East and Africa In-Vitro Diagnostics Market Share, By Application, 2024 & 2032 (%)

Figure 64 Middle East and Africa In-Vitro Diagnostics Market Share, By End-User, 2024 & 2032 (%)

Figure 65 bioMerieux: Financials

Figure 66 Becton, Dickinson and Company: Financials

Figure 67 Beckman Coulter, Inc: Financials

Figure 68 F. Hoffmann-La Roche Ltd.: Financials

Figure 69 Bio-Rad Laboratories, Inc: Financials

Figure 70 Abbott Laboratories: Financials

Figure 71 Qiagen NV: Financials

Figure 72 FUJIFILM Holdings Corporation: Financials

Figure 73 Sysmex Corporation: Financials

Figure 74 Siemens Healthineers AG: Financials

글로벌 체외 진단 시장 – 2024년 – 2031년

Global In-Vitro Diagnostics Market - 2024 - 2031